Candida albicans is the most prevalent fungal pathogen in humans and a major source of life-threatening nosocomial infections. The Als (agglutinin-like sequence) glycoproteins are an important virulence factor for this fungus and have been associated with binding of host-cell surface proteins and small peptides of random sequence, the formation of biofilms and amyloid fibers. High-resolution structures of N-terminal Als adhesins (NT-Als; up to 314 amino acids) show that ligand recognition relies on a motif capable of binding flexible C termini of peptides in extended conformation. Central to this mechanism is an invariant lysine that recognizes the C-terminal carboxylate of ligands at the end of a deep-binding cavity. In addition to several protein-peptide interactions, a network of water molecules runs parallel to one side of the ligand and contributes to the recognition of diverse peptide sequences. These data establish NT-Als adhesins as a separate family of peptide-binding proteins and an unexpected adhesion system for primary, widespread protein-protein interactions at the Candida/ host-cell interface.
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NMR | X-ray crystallography | microbial adhesion | tissue tropism B reakdown in host immunity or alterations in the normal microbiota are common precursors to disease caused by Candida species, with Candida albicans the most frequent causative agent. Adhesion of the fungus to host surfaces correlates positively with the pathogenic potential of different Candida species (1) . These adhesive properties manifest in different forms, such as attachment to different cell types, binding to specific proteins on the host cell surface and in the ECM, autoaggregation, and the development of biofilms. Although many Candida cellwall proteins have been identified, molecular mechanisms of interaction with the host remain poorly understood. Among the most-studied C. albicans proteins implicated in this property are the Als (agglutinin-like sequence) cell-surface glycoproteins (2) . Eight genetic loci encode Als proteins that are designated Als1 to Als7 and Als9; ALS9 alleles encode proteins with distinct N-terminal domains (Als9-1 and Als9-2) (3). Als proteins are composed of a signal peptide, an N-terminal region with 41-84% identities among sequences in C. albicans, a nonrepeat Thr-rich (TR) region of 103aa., a central region with a variable number of 36aa. repeats, and a Ser/Thr/Asn-rich C-terminal domain of variable length that attaches the protein to the cell wall via the remnant of a GPI anchor (3) . Extensive N-and O-glycosylation are observed in the central and C-terminal domains (4) . Unlike the highly glycosylated nature of the central and C-terminal domains of Als proteins, the N-terminal region is predicted to form an Ig-like structure and has been directly implicated in the binding of cell surfaces (5) .
Heterologous expression of individual ALS genes is sufficient to confer upon Saccharomyces cerevisiae the adhesive/aggregative properties observed in C. albicans (6), and cell-based experiments suggest that Als proteins bind a range of host-cell and ECM proteins including fibronectin, laminin, casein, BSA, type IV collagen, cadherins, and ferritin (7) (8) (9) (10) . Furthermore, C. albicans or otherwise nonadherent S. cerevisiae expressing Als1 and Als5 can efficiently bind 0.1-10% of beads loaded with a library of 10 7 random heptapeptides (11) . Previous studies raise two important questions: How can Als proteins recognize such a structurally diverse set of ligands, and how is this activity related to the broad tissue tropism displayed by C. albicans? For a detailed description of the binding mechanism of these proteins, we solved the crystal structures of the 33-kDa N-terminal (NT) region from Als9-2 in the presence and absence of ligands. A preliminary solution structure of NT-Als1 and binding analyses of these adhesins were also obtained by NMR.
Results
NT-Als Adhesins Adopt an Ig-Like MSCRAMM (Microbial Surface Components Recognizing Adhesive Matrix Molecules) Architecture. We have determined the structure of NT-Als9-2 in complex with a peptide from the C-terminal end of human fibrinogen gamma, Fg-γ (NH 3 -GEGQQHHLGGAKQAGDV-CO 2 ). The structure shows that NT-Als adhesins comprise two tandem DEv-IgG type immunoglobulin domains (12), N1 and N2 (Fig. 1) , arranged in a fold reminiscent of MSCRAMM domains, as those in bacterial adhesins ClfA from Staphylococcus aureus (13) and SdrG from Staphylococcus epidermidis (14) (Fig. S1 ). Notable structural differences include the presence of four conserved intradomain disulfide bonds, an α-helix in the interdomain region (α1), and a small β-strand essential for ligand binding (C1 Ã ) (Fig. S2 ), but the relative domain-domain orientation is retained, as judged by the rmsd of ca. 5 Å between NT-Als9-2 and these MSCRAMMs (Fig. S1 ), plus residual dipolar coupling and small-angle X-ray scattering (SAXS) data (Fig. S3 ).
NT-Als Adhesins Have a Cavity to Bind Peptides with Broad Specificity.
Details of the interactions of NT-Als9-2 with the Fg-γ peptide are described in Fig. 1 (an electron density map is shown in Fig. S4 ). In this complex, the ligand binds in a cavity formed by βG2b and βA2 and is covered by the long A1-B1 loop from domain N1.
A cluster of conserved, bulky side chains defines the end of this binding cleft and prevents the peptide from crossing the interdomain region and reaching N1 (Fig. 1B) . The bound peptide also makes extensive interactions with conserved hydrophobic side chains (Y21, L295, W297, and Y301). Notably, the side chain amine of an invariant lysine (K59) at the end of the cavity establishes a salt bridge with the C-terminal carboxylic acid of the incoming peptide (Fig. 1B) . This interaction explains the preference for binding free peptide C termini and sets the initial register for the parallel hydrogen bonding pattern between the ligand and βG2b (Fig. 2) . To our knowledge, the specific recognition of the C-terminal carboxylate is an exclusive property of NT-Als adhesins relative to other families of peptide-binding proteins (PBPs) (15, 16) .
Apart from these structural features, NT-Als adhesins depend on additional interactions to bind peptides with broad specificity. Analysis of sequence conservation shows that surface variability is mainly localized in the vicinity of the ligand, i.e., at positions that induce changes in the shape and chemical properties of the binding cavity (β-strands A2, B2, F2a/b, G2a/b, and the A1-B1 loop) (Fig. 3) . In common with other PBPs, contacts with the ligand are also aided by water-mediated hydrogen bonds. A network of water molecules allows a malleable interaction between βA2 and the side chains of different peptides, whereas their backbones adopt a β-strand parallel to βG2b (Fig. 2 and Table S1 ). Small rearrangements in the flexible A1-B1 loop also contribute to the observed broad peptide-binding specificity.
Ligand Binding Studies of NT-Als Adhesins. NT-Als1 and NT-Als9-2 are monomeric in solution, as judged by size exclusion chromatography, SAXS, and NMR relaxation experiments (Figs. S3 and S5). Surprisingly, however, in the absence of peptides we observe that these adhesins recognize their own C termini as ligands, as illustrated in the crystal structure of NT-Als9-2, in which the C-terminal end is found in the binding cavity of a neighboring adhesin (Fig. 4A and Fig. S6A ). Similarly, in an attempt to reduce the flexibility of this C terminus, we tested if introduction of a bulky side chain in a cavity at the interdomain region could induce the conformation of βG2′ observed in the NT-Als9-2/Fg-γ complex. Unexpectedly, the crystal structure of the G299W mutant shows that the C-terminal end folds back to self-complement its own binding site ( Fig. 4B and Fig. S6B ). Using NMR, a com- ; underlined residues correspond to modeled peptide (red), as identified in the electron density (Fig. S4A) . Structural elements involved in ligand binding are highlighted: β-strands A2 and G2b (yellow), G2′ (purple), loop A1-B1 (cyan), and a small β-strand containing K59 (dark blue). (B) Representation of key residues involved in ligand binding (F293, L295, W297, yellow spheres) and hydrophobic residues at the end of the binding cavity (V19, P29, I61, F58 and Y301, purple spheres). A dashed line shows the interactions between K59 and the C-terminal end of the peptide. The aminoacid numbering across the text is based on the sequence alignment of C. albicans NT-Als adhesins shown in Fig. S2 . The C-terminal valine of human fibrinogen-γ (V437) is also indicated. interactions conserved in all complexes described in this paper are indicated by gray dashed lines. Conserved K59 is colored in dark blue. In these complexes, hydrogen bond interactions are between protein and ligand atoms, including those mediated by bound water molecules. C was produced using LIGPLOT (39) .
parable effect is observed in NT-Als1: We have identified NOEs (nuclear Overhauser effects) between residues in the binding cavity and the C-terminal residues V314 and A315, indicative that the binding pocket of this adhesin is also complemented in solution by its own C terminus via intra-or interdomain interactions ( Fig. 4C and Fig. S7 ). This is confirmed by NMR dynamics measurements (T 1 , T 2 relaxation and heteronuclear NOE) for backbone amides of NT-Als1, which show that C-terminal residues I311-A315 have relaxation rates comparable to the folded part of the protein, whereas connecting residues D305-G310 are largely unstructured, i.e., exhibiting faster internal motion on the nanosecond-picosecond time scale (Fig. S5A) .
It is important to emphasize that the C-terminal end of NT-Als is not available for these interactions in vivo because the NT domain is only one portion of the much larger Als molecule. Similarly, the very C-terminal end of the full-length Als protein is not available for these interactions in vivo because it is attached by a GPI anchor remnant to the Candida cell wall. As a result, the self-complemented structures do not reflect the true conformation of the C-terminal residues of NT-Als adhesins in the apo form. However, they suggest that this region is flexible in the absence of ligands. Self-complementation by endogenous NT-Als C-terminal sequences (which were selected arbitrarily for production of folded, soluble NT-Als fragments) supports the conclusion that Als adhesins have a broad specificity for peptide binding.
Upon binding of Fg-γ peptide, the C-terminal end of NTAls9-2 extends away from N2 to form the new strand (βG2′) over N1, resembling the ligand bound conformation of bacterial MSCRAMMs (Fig. 1A) . Also notable is the change in orientation of conserved Y301: Solvent-exposed in the self-complemented forms, it flips 180°to form a hydrogen bond with the buried K59. The presence of the peptide also induces alterations in the conformation of the A1-B1 loop, now in contact with the ligand and flanked by the newly formed C-terminal strand, rendering it less flexible, as indicated by better defined electron density and lower B factor values (Fig. S5B) .
To test whether these interactions can be displaced by free peptides in solution, we recorded two-dimensional NMR spectra of 15 N labeled NT-Als1 and 9-2 titrated with a threonine heptamer (NH 2 -TTTTTTT-CO 2 ) and the Fg-γ peptide, respectively. In both cases, a large number of chemical shift changes occur upon titration, which indicates that binding induces a structural transition between free and bound forms (Fig. 5A and Fig. S8A ). In NT-Als1, the largest shift changes map to residues in the binding pocket (A19 and K59), the C terminus (I308 and A311), and others that interact with βG2′ (e.g., D72 and K106) (Fig. 5B) , in a pattern consistent with the conformation of the ligand bound crystal form of NT-Als9-2. Simultaneous disappearance and appearance of peaks from free and bound conformations, respectively, is indicative of binding in the "slow exchange regime" on the NMR time scale, as shown for the backbone amide of A315 from NT-Als1 (Fig. S8B) . Assuming a diffusion-controlled on rate (k on ), this result suggests dissociation constants K D smaller than approximately 10 μM (17). In these conditions, no chemical shift changes were observed on titration of NT-Als1 with the Fg-γ peptide or NT-Als9-2 with the threonine heptamer.
An Invariant Lysine (K59) and a Free C-Terminal Carboxylate Are Essential for Ligand Binding. In agreement with the observation of a salt bridge between K59 and the ligand C-terminal carboxylate in different crystallographic complexes, C-terminal amination of peptides is sufficient to abolish binding, as indicated by an absence of protein shift changes after addition of up to 100 equivalents of ligand. Similarly, cocrystallization of NT-Als9-2 with C-terminally aminated Fg-γ peptide results in crystals where only the apo form is identifiable. Interestingly, proton NMR spectra demonstrate that the K59M and K59V mutants in NT-Als9-2 are sufficient to induce folding defects in these adhesins, suggesting that interactions with this residue might also be involved in protein stability (Fig. S8C) . A similar analysis was not possible for NT-Als9-2 K59R, K59E, and K59A mutants, as they induce reduced protein yields in our Escherichia coli expression system and aggregation after protein purification.
Discussion
The conformation of NT-Als9-2 in complex with the Fg-γ peptide is reminiscent of the proposed "dock, lock, and latch" mechanism described for the binding of SdrG and ClfA to their specific ligands (18) . However, the mode of ligand recognition of Als proteins is distinct. In bacterial MSCRAMMs, the peptide-binding site is distributed on both Ig-like domains, leaving the N-and C termini of the ligand exposed to the solvent. In contrast, the peptide-binding mechanism for Als proteins is inconsistent with the recognition of unstructured interdomain/loop regions or the surface of folded domains: The binding cavity in the N2 domain is limited to contain up to six residues of the ligand, whereas the requirement to neutralize the buried charge of K59 provides specificity for the C termini of incoming unstructured peptides. Importantly, this mechanism is supported by published observations that Als proteins are able to bind a large range of structurally unrelated proteins and peptides from randomly generated sequences.
Despite the ability to recognize a range of unrelated substrates, there are documented differences in ligand specificity between Als proteins (10, 11) , potentially due to variations in C-terminal peptide sequences that can be accommodated in the binding clefts of their respective N-terminal adhesins. Our structural data suggest that in vivo, these adhesins identify overlapping subsets of C-terminal sequences on the surface of host cells and the ECM (Fig. 6 A and B) . Association to different ligands is likely enhanced by avidity effects from multiple interactions in the microbial host-cell interface and increased expression of Als proteins, as in the case of Als1 and Als3 (19) .
Moreover, genes from a family of 10 secreted aspartyl proteinases (Sap1-10) are differentially expressed by C. albicans during infection (20) . Genomic transcriptional profiling shows a comparable up-regulation pattern for Als1, Als3, and Sap5 (with maximal expression levels at 3 h) in an intraperitoneal mouse model (21) . Intriguingly, Saps have been directly implicated in Candida adherence (22) , but the molecular mechanism underlying their involvement in these events has not been established. In this scenario, it is conceivable that proteolysis could increase Alsmediated adhesion by creating additional C termini as potential new ligands (Fig. 6 C-E) ; alternatively, proteolytic peptides released by the action of Saps might inhibit Als-mediated adhesion.
In addition to the peptide-binding mechanism described, C. albicans adhesion has been associated to the aggregative properties of regions beyond the NT-Als domains, the amyloidogenic and glycosylated sequences involved in the formation of biofilms (23, 24) . In this regard, it has been shown that the TR region adjacent to the NT-Als domains contains a conserved amyloidogenic motif (25) , important for hydrophobic clustering and the formation of "nanoadhesomes" (26) . The NT-Als9-2/Fg-γ peptide complex shows that this region (-GIVIV-in Als1 and 5) is part of the C-terminal βG2′ that docks over the surface of N1, i.e., preceding the TR region. Interestingly, substitution of V312 to N (GIVIV) in Als5 decreases formation of amyloid fibrils in vitro, as a purified protein or expressed on the yeast cell surface (27) . The structural transitions of this region on the surface of C. albicans and their functional implications remain to be determined.
More recently it has been shown that a fragment encompassing residues 18-432 of Als1 recognizes different fucose-containing sugars from a glycan array (28) . The authors also demonstrate that the interaction of this fragment with a glycoconjugate of fucose and BSA has a dissociation constant in the submillimolar range (K D ¼ 210 μM), which opens the possibility that Als proteins can specifically recognize fucose-related glycans or glycoproteins in the peptide-binding cavity or an alternative binding site.
Crucially, the peptide-binding properties of NT-Als adhesins provide a promiscuous mode of molecular recognition, as they overcome the strict "domain-to-domain" surface complementarity observed in most interactions between microbial adhesins and host-cell receptors. Our structural data pave the way to study the intriguing idea that changes in Candida physiology can be promoted by the interplay of Als and other fungal cell-wall proteins (29) . Similarly, they offer important clues for ongoing development of Als-based anti-Candida vaccines (30) . Conserved features in the deep-binding cavity of these adhesins suggest a template for the design of drugs that block key interactions between Candida and host cells. 
Materials and Methods
We expressed and purified the 33-kDa N-terminal adhesins of Als1 and Als9-2 in E. coli as described (31, 32) . The Quikchange mutagenesis kit (Agilent Technologies) was used to generate NT-Als9-2 mutants G299W, K59 to M, V, R, A, and E.
Crystallographic Data Collection, Processing and Structure Refinement. For NT-Als9-2 crystals in the peptide free form, a dataset to 2.0-Å resolution was collected in beamline BM14, European Synchrotron Research Facility, at 100 K, wavelength 0.9785 Å, using MARmosaic 225 detector with 1º oscillation per image and processed using HKL2000 (33) (see Table S3 for details). Diffraction data for NT-Als9-2 crystals with bound peptide to 1.5 Å were collected at 100 K in beamline I03, Diamond Light Source, using an ADSC (Area Detector Systems Corporation) 315r detector with 1º oscillation per image and processed using HKL2000, as detailed in Table S3 . For NT-Als9-2 G299W, data were collected at PROXIMA1 beamline, Synchrotron SOLEIL, with a wavelength of 0.9919 Å, and data were processed using XDS (34) . For all crystal forms, initial phases were calculated with Phaser (35) using a refined Pt-derived NT-Als9-2 model (31), within the CCP4 program suite (36) . Iterative cycles of model building and refinement were carried out using COOT (37) and REFMAC5 (38) , respectively, to determine the final models.
Binding and Relaxation Analyses of NT-Als1 by NMR. For observation of chemical shift changes upon ligand binding, 15 N NT-Als1 (concentrated to 200 μM in 50 mM sodium phosphate pH 6.0, 50 mM NaCl, 10% D 2 O) was titrated with 0.75, 2, 7.5, 20 and 50 M equivalents of a threonine heptamer (NH 3 -TTTTTTT-CO 2 ). 15 N NT-Als9-2 (150 μM) was titrated with 100 M equivalents of Fg-γ peptide (Fig. S8 ). Changes were monitored by 1 H 15 N TROSY-HSQC NMR spectra recorded in a 600-MHz magnet at 308 and 303 K for NT-Als1 and NT-Als9-2, respectively. Rms deviations of Cα carbons from equivalent residues after rigid-body superimposition were calculated with DaliLite (3) a Structurally equivalent residues after rigid-body superimposition. b Pairwise sequence identity (%) over structurally equivalent residues. . Residual dipolar coupling (RDC) and small-angle X-ray scattering (SAXS) data for NT-Als adhesins. (A) Predicted NMR alignment tensor axes for the (independently fitted) two domains of NT-Als9-2 using 1 H-15 N and 13 C α -13 C 0 RDCs measured for NT-Als1. The variation in predicted tensor axes over 100 Monte Carlo simulations is indicated by the blue and yellow dot scatter on each axis. The alignment axes are essentially coincident apart from a small rotation (approximately 14°) about the principal axis, which is outside of the scatter (SD of AE2.8 and AE3.3°for domains 1 and 2, respectively), indicating that the domain arrangement of NT-Als1 in solution is on average very close to that of NT-Als9-2 in the crystal. The RDC Q factor (1) is 0.36 over 307 measured RDCs. Analysis performed using Module v.2 (2). (B) SAXS data for NT-Als1 at 16.3 mg∕mL in 50 mM Na phosphate, 300 mM NaCl, pH 8.0 were recorded at the X33 beamline of European Molecular Biology Laboratory (Deutsches Elektronen-Synchrotron). Scattering data across the q range 0.07 to 0.49 Å −1 were obtained using a 2-min exposure and were processed in the standard manner using PRIMUS (3). The radius of gyration (Rg), scattering at zero angle (Ið0Þ), and distribution function (PðrÞ) were subsequently calculated using GNOM (4). An ensemble of 100 ab initio dummy-residue models was calculated using GASBOR (5) according to default parameters. Models were ranked according to their overall fit to the experimental data (Chi value) and the best 12 models were aligned and averaged by DAMAVER (6) to yield the final SAXS envelope. Coordinates of the NMR structure of NT-Als1 (C) and NT-Als9-2 (D) were fitted into the SAXS dummy-residue model by SITUS (7). (1) . Subsequently, 79% of Hα and Hβ assignments were obtained from HBHA(CO)NH, HCCH-TOCSY, and (H)CCH-TOCSY spectra. Using these data, 256 reliable dihedral angles were derived using TALOSþ (2) . Cysteine mutants at four different positions (S200, 202, 229, and 234) allowed labeling of NT-Als1 with oxidized methanethiosulfonate (3). Using these samples, 1 H-15 N heteronuclear sequential quantum correlation (HSQC) spectra were recorded for identification of 49 PRE (paramagnetic relaxation enhancement) distance restraints (4). Simultaneous 15 N∕ 13 C NOESY HSQC spectra provided HN to HN, CH 3 to CH 3 , and HN to CH 3 NOESY cross-peaks. The overall arrangement of secondary structure elements was constructed by identifying continuous stretches of NOEs between HN atoms of β-strands predicted by Chemical Shift Index, CSI (5). After inspection of NOESY cross-peak assignments in successive structure calculation runs, 1,165 NOEs (238 ambiguous, 927 unambiguous) were also added as restraints in the final structure calculation using ARIA 2.2. Data were processed with NMRPipe (6) and analyzed with NMRview (7) . Although further refinement is under way, the current NT-Als1 family of structures has an rmsd of 2.41 Å over backbone atoms and is consistent with the fold, orientation of domains and mode of ligand binding observed for NT-Als9-2. A cartoon representative of structures from the preliminary ensemble of NMR structural models of NT-Als1 is shown in Fig. 4C . Interacting residues from the protein and peptide (uppercase and lowercase, respectively), are indicated in the first column, whereas corresponding water molecules within H-bond distance are indicated in the first row. The boxes describe the interacting atom of the residue and distance in angstroms. One crystal was used for data collection for each crystal form. *Highest resolution shell is shown in parenthesis.
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